Volunteer Donate Get Help

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

Hodgkin Lymphoma Treatment in EU vs US

Published: February 22, 2019

Author: John Schieszer, MA

Source: Oncology Nurse Advisor

Worldwide clinical trials may greatly improve and enhance management of Hodgkin lymphoma, according to a recent article published in Clinical Medicine Insights: Oncology. Thomas J. FitzGerald, MD, a ... More >>.

Outcomes in Patients with Burkitt Lymphoma

Published: February 14, 2019

Author: Susan Moench, PhD, PA-C

Source: Oncology Nurse Advisor

A retrospective study of patients with early-stage Burkitt lymphoma showed significant improvements in overall survival (OS) for those diagnosed with the disease between 2002 and 2014 compared with 1983 and ... More >>.

Benefit of Decitabine Treatment

Published: January 25, 2019

Author: Susan Moench, PhD, PA-C

Source: Oncology Nurse Advisor

A retrospective analysis of older patients with acute myeloid leukemia (AML) treated with the hypomethylating agent decitabine at eight Italian hematological centers from 2015 to 2017 supports the efficacy a ... More >>.

Mechanism for Leukemia Cell Growth Revealed

Published: January 16, 2019

Source: University of Sussex

A mechanism which drives leukemia cell growth has been discovered by researchers at the University of Sussex, who believe their findings could help to inform new strategies when it comes to treating the canc ... More >>.

More Accurate Leukemia Diagnosis Expected

Published: January 14, 2019

Source: St. Jude Children's Research Hospital

Like cartographers completing a map, investigators have identified multiple new subtypes of the most common childhood cancer---research that will likely improve the diagnosis and treatment of high-risk patie ... More >>.

MD Anderson and Ascentage Pharma Alliance

Published: January 06, 2019

Source: MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Ascentage Pharma Group, today announced a five-year strategic agreement to advance the development of five potential new cancer therapies.

The al ... More >>.

U.S. Senate Introduces Cancer Drug Parity Act

Published: December 12, 2018

Source: Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (LLS) is proud to support the Cancer Drug Parity Act. which will ensure equality of insurance coverage for all cancer treatments, regardless of how these treatments are ad ... More >>.

Tailoring Treatment for AML

Published: December 07, 2018

Source: University of Washington Heath Science

Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

Research on the dru ... More >>.

Combination Chemotherapy and Immunotherapy Effective

Published: November 08, 2018

Source: University of Texas M.D. Anderson Cancer Center

A combination of the standard-of-care chemotherapy drug know as azacytidine, with nivolumab, an immune checkpoint inhibitor, demonstrated an encouraging response rate and overall survival in patients with re ... More >>.

LLS Committing $188 Million

Published: November 08, 2018

Source: Leukemia & Lymphoma Society

Driving the dizzying pace of breakthroughs in blood cancer treatments, The Leukemia & Lymphoma Society (LLS) announced today $42 million for 80 blood cancer research teams around the world.

The l ... More >>.

©2015 Stephanie Robinson Foundation | Privacy Policy